After 72 h, we observed a decrease in the percentage of proliferating cells in the presence of 1:10 NSEO in healthy women and HT patients for each T cell subpopulation (CD4+ and CD8+); see Figure 3a,c. The gene discussed is CD4; the disease is hematocrit.